20
Medinex Laboratories Private Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
They are recognized for Medinex Group specializes in the manufacture of Adrenaline based niche APIs.
One of their significant offerings is Noradrenaline tartrate, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2014-363 - Rev 00
This Chemical Type CEP, issued on January 09, 2017, remains in force until February 20, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 285 associated with this CEP further emphasizes